These results suggest that Stage II/III RS cancer should be classified as colon cancer and should not be considered an independent tumor type. In the Stage III group, survival rates were 71.6/77.7% for RSC, 47.6/44.8% for Ra, and 45.7/51.3% for Rb, with significant differences for RSC vs. If it's not what You are looking for type in the equation solver your own equation and let us solve it. Our solution is simple, and easy to understand, so dont hesitate to use it as a solution of your homework. Check how easy it is, and learn it for the future. RSC, but significant differences were noted for CC vs. Simple and best practice solution for 2y2+5y+3(y+3)(y+3) equation. There was no significant difference of survival for CC vs. In the Stage II group, the survival rates were 82.9/81.2% for CC, 77.6/74.8% for RSC, and 72.9/80.5% for RC, with no significant differences between each category. This is of the form y mx + c, where m is the slope and c is the y-intercept. Then the 5Y-RFS and 5Y-OS were calculated for each category or subcategory. Stage III patients with RC were further divided into 68 patients with Ra cancer (Ra, rectum/above the peritoneal reflection) and 23 patients with Rb cancer (Rb, rectum/below the peritoneal reflection). The Stage II group included 283 patients with colon cancer (CC), 40 patients with rectosigmoid junction cancer (RSC), and 74 patients with rectal cancer (RC), while the Stage III group comprised 226 patients with CC, 52 patients with RSC, and 91 patients with RC. The 5-year relapse-free survival rate (5Y-RFS) and 5-year overall survival rate (5Y-OS) were investigated in 766 patients with stage II/III colorectal cancer (CRC).

5y 3